Targeting TNF-Alpha in HIV-1 Infection

E-ISSN： 1873-5592|17|1|15-22

ISSN： 1389-4501

Source： Current Drug Targets, Vol.17, Iss.1, 2016-01, pp. : 15-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting TNF-Alpha to Elucidate and Ameliorate Neuroinflammation in Neurodegenerative Diseases

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 3, 2011-05 ,pp. : 391-403

Bentham Science Publishers

Access to resources Recommend Favorite

The influence of toll-like receptor (TLR-) agonists on lysozyme activity, TNF-alpha secretion and intercellular adhesion in THP-1 cells

By Schopohl P. Melzig M. F.

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 69, Iss. 8, 2014-08 ,pp. : 602-609

Govi-Verlag

Access to resources Recommend Favorite

Targeting HIV-1 integrase

By Yelle Jocelyn Sauvé Gilles Sayasith Khampoune

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 4, 2001-08 ,pp. : 443-464

Informa Healthcare

Access to resources Recommend Favorite

Aspirin, TNF-alpha, NFkB, and survival in multiple myeloma: the importance of measuring TNF-alpha

By Kast R.

Inflammopharmacology, Vol. 14, Iss. 5-6, 2006-12 ,pp. : 256-259

Springer Publishing Company

Access to resources Recommend Favorite

Targeting Chemokine Receptor CXCR4 for Treatment of HIV-1 Infection, Tumor Progression, and Metastasis

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 13, 2014-07 ,pp. : 1574-1589

Bentham Science Publishers

Access to resources Recommend Favorite